The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for HydroCision sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
HydroCision is a medical device company that offers commercialization of proprietary fluidjet technology and provides surgical equipment. The company develops, manufactures and markets fluidjet based surgical tools for the spine market. It provides products such as spinejet systems, spinejet XL, hydrodiscectomy system and allograft systems, among others. HydroCision provides spinejet instruments to ablate, cut and remove targeted tissue. The company’s fluidjet technology is designed to control a hair-thin, supersonic stream of water used for precise tissue resection. Its allojet system provides a safer, faster and cleaner way to prepare bone allografts. The company markets its products through its network of distributors. HydroCision is headquartered in Billerica, Massachusetts, the US.
The key metrics of HydroCision related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As HydroCision is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as HydroCision.
For a detailed understanding of the performance of HydroCision, buy the report here.